Genetics in inclusion body myositis

Area of Science:

• Genetics
• Immunology
• Neurology

Background:

• Inclusion body myositis (IBM) is a progressive idiopathic inflammatory myopathy.
• Its pathogenesis is complex, involving inflammatory, degenerative, and mitochondrial pathways.

Purpose of the Study:

• To review recent advancements in understanding the genetics of inclusion body myositis (IBM).

Main Methods:

• Genetic association studies focusing on immune-related genes.
• Sequencing studies of candidate genes.
• Proteomic analysis of rimmed vacuoles.
• Analysis of mitochondrial DNA.

Main Results:

• Refined association within the human leukocyte antigen (HLA) region to HLA-DRB1 alleles.
• Identified potential genetic overlap with autoimmune diseases via CCR5.
• Discovered rare variants in VCP, SQSTM1, and FYCO1.
• Confirmed complex mitochondrial deletions in affected muscle fibers.

Conclusions:

• IBM pathogenesis is multifactorial, involving inflammation, degeneration, and mitochondrial dysfunction.
• Complementary genetic approaches are crucial for unraveling IBM's complex genetic architecture.